Correction to: Treating ICB-resistant cancer by inhibiting PD-L1 via DHHC3 degradation induced by cell penetrating peptide-induced chimera conjugates (Cell Death & Disease, (2024), 15, 9, (701), 10.1038/s41419-024-07073-y)

doi:10.1038/s41419-024-07182-8

UM > Faculty of Health Sciences

Residential College	false
Status	已發表Published
	Correction to: Treating ICB-resistant cancer by inhibiting PD-L1 via DHHC3 degradation induced by cell penetrating peptide-induced chimera conjugates (Cell Death & Disease, (2024), 15, 9, (701), 10.1038/s41419-024-07073-y)
	Shi, Yu Ying 1; Fan, Gang 2; Tan, Ruirong 3; Li, Shan 1; Sun, Hua Bing 4; Li, Rui 5; Yang, Mengni 3; Gao, Shanshan 6; Liu, Miao 7; Dai, Meng Yuan 1
	2024-11
Media	CELL DEATH & DISEASE
DOI	10.1038/s41419-024-07182-8
Language	英語English
URL	View the original
Scopus ID	2-s2.0-85210014485
Fulltext Access	View Full-Text via DOI View Full-Text via Web of Science View Full-Text via Scopus
Citation statistics
Document Type	Other
Collection	Faculty of Health Sciences DEPARTMENT OF BIOMEDICAL SCIENCES
Corresponding Author	Liu, Miao; Dai, Meng Yuan
Affiliation	1.Department of Gynecological Oncology, Zhongnan Hospital of Wuhan University, Wuhan, China 2.Department of Urology, Huazhong University of Science and Technology Union Shenzhen Hospital, Shenzhen, China 3.China Translational Chinese Medicine Key Laboratory of Sichuan Province, State Key Laboratory of Quality Evaluation of Traditional Chinese Medicine, Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Chengdu, China 4.Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Department of Nuclear Medicine, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China 5.Department of Radiation Oncology, Radiation Oncology Key Laboratory of Sichuan Province, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, Chengdu, China 6.Department of Biomedical Sciences, Faculty of Health Sciences, University of Macau, Taipa, Macao 7.Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, United States
Recommended Citation GB/T 7714	Shi, Yu Ying,Fan, Gang,Tan, Ruirong,et al. Correction to: Treating ICB-resistant cancer by inhibiting PD-L1 via DHHC3 degradation induced by cell penetrating peptide-induced chimera conjugates (Cell Death & Disease, (2024), 15, 9, (701), 10.1038/s41419-024-07073-y). 2024-11-01.

Files in This Item:
There are no files associated with this item.

If you have any objections to this item, please fill out the form below and the administrator will contact you as soon as possible.
Content:
Email：	*
Affiliation No.
Verification Code:	Refresh

Any comments and suggestions are welcomed.
Title:	*
Content:
Email：	*
Verification Code:	Refresh